Compare ATRC & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | DHC |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | 585 |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2005 | N/A |
| Metric | ATRC | DHC |
|---|---|---|
| Price | $29.95 | $6.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $51.17 | $7.25 |
| AVG Volume (30 Days) | 545.5K | ★ 2.1M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.60% |
| EPS Growth | ★ 74.74 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $201,630,000.00 | N/A |
| Revenue This Year | $15.17 | $3.13 |
| Revenue Next Year | $12.42 | $7.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $28.32 | $2.00 |
| 52 Week High | $43.18 | $7.66 |
| Indicator | ATRC | DHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 50.39 |
| Support Level | $28.69 | $3.93 |
| Resistance Level | $32.85 | $7.64 |
| Average True Range (ATR) | 1.14 | 0.36 |
| MACD | 0.20 | -0.09 |
| Stochastic Oscillator | 37.59 | 21.86 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.